Lebrikizumab for adolescent atopic dermatitis: 24-week real-world outcomes from the Czech BIOREP registry

JAAD International 2026 Open access

Read full text
Authors: Filip Rob, Blanka Pinková, Petra Gkalpakioti, Jiřina Bartoňová, Jiří Horažďovský, Jan Říčař, Jana Třešnák Hercogová, K. Yu. Sokolova
DOI: 10.1016/j.jdin.2026.01.009
Cited by: 1
References: 3

Abstract

Lebrikizumab for adolescent atopic dermatitis: 24-week real-world outcomes from the Czech BIOREP registry

Fields of Study & Subjects

Dermatology and Skin Diseases Psoriasis: Treatment and Pathogenesis Asthma and respiratory diseases

Publication details

Journal / source
JAAD International
Publisher
Elsevier BV
Volume
25
Pages
130–132
Publication date
1 February 2026
Language
EN